×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 9 Track A: Globalization of Medical Communications and Contact Center – What Can We Learn from Orphan Drug, Rare Disease, and Specialty Company Experiences
Session Chair(s)
Michael Burman, PharmD, RPh
Vice President, Global Medical Information
ProPharma Group, United States
Globalization of medical communications, from content to contact, continues to be a focus for many companies. Case studies will be highlighted from orphan drug, rare disease, and specialty companies to understand their motives, their approach, and most importantly, to identify what we can learn from their experience. Are there best practices and challenges associated with globalization that transcend company size? This session will include time for discussion and participation.
Learning Objective : At the conclusion of this session, participants should be able to:- Evaluate reasons and different models for globalizing medical communications
- Identify challenges faced by orphan drug/rare disease companies in globalizing their medical communication organizations
- Apply lessons learned and best practices from orphan drug/rare disease companies to any size or type of company
Speaker(s)
Globalization Case Study for a Rare Disease Company
Kristen Morris, MSc
United States
Globalization Case Study from a Specialty Company Perspective
Nancy Norgeot Dougherty
Seqirus, United States
Director Medical Communications and Information/Medical Affairs
Have an account?